Moderna (MRNA) Q4 2022 Earning Report Analysis
- Quarterly revenue: $5.08 billion, a 6% decrease from Q3 2022;- Quarterly earnings: $3.61 per share, a 35% decrease from Q3 2022;- Lowered 2023 revenue guidance for Covid vaccine sales…
Thematic investing involves identifying and analyzing broader trends or themes that are driving change in the economy or a particular industry. These themes can be based on social, economic, technological, environmental or political factors, and may include things like demographic shifts, changing consumer preferences, or advancements in technology. Thematic analysis helps investors identify companies that are likely to benefit from these trends or themes and invest in them before the market catches up. This can lead to significant returns if the investor is correct in their analysis.
- Quarterly revenue: $5.08 billion, a 6% decrease from Q3 2022;- Quarterly earnings: $3.61 per share, a 35% decrease from Q3 2022;- Lowered 2023 revenue guidance for Covid vaccine sales…
- Quarterly revenue: $222.6 billion RMB, up 7.4% quarter over quarter;- Quarterly earnings: $1.82 per share, up 21.3% quarter over quarter;- Product focused on new initiatives such as cloud computing,…
- The company reported a quarterly revenue of $451 million, which was a 43% increase year-over-year.- The company reported a net loss of $144.7 million for Q3 2022, compared to…